Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia
基于网络的系统药理学揭示了LCK和BCL2信号传导的异质性以及T细胞急性淋巴细胞白血病的治疗敏感性
期刊:Nature Cancer
影响因子:23.5
doi:10.1038/s43018-020-00167-4
Yoshihiro Gocho # ,Jingjing Liu # ,Jianzhong Hu # ,Wentao Yang ,Neekesh V Dharia ,Jingliao Zhang ,Hao Shi ,Guoqing Du ,August John ,Ting-Nien Lin ,Jeremy Hunt ,Xin Huang ,Bensheng Ju ,Lauren Rowland ,Lei Shi ,Dylan Maxwell ,Brandon Smart ,Kristine R Crews ,Wenjian Yang ,Kohei Hagiwara ,Yingchi Zhang ,Kathryn Roberts ,Hong Wang ,Elias Jabbour ,Wendy Stock ,Bartholomew Eisfelder ,Elisabeth Paietta ,Scott Newman ,Giovanni Roti ,Mark Litzow ,John Easton ,Jinghui Zhang ,Junmin Peng ,Hongbo Chi ,Stanley Pounds ,Mary V Relling ,Hiroto Inaba ,Xiaofan Zhu ,Steven Kornblau ,Ching-Hon Pui ,Marina Konopleva ,David Teachey ,Charles G Mullighan ,Kimberly Stegmaier ,William E Evans ,Jiyang Yu ,Jun J Yang
BCL2
白血病
LCK
细胞生物学
信号转导
T细胞
免疫/内分泌
T细胞